Beijing, April 2, 2021 (AFP): Chinese biopharmaceutical firm Sinovac said on Friday a third production line for its Covid-19 vaccine has been put into use, doubling its annual capacity of the jabs to two billion doses.
Its CoronaVac is one of four domestic vaccines given conditional approval by Chinese authorities, which helps rush emergency drugs to market.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!